ITEM 5.07 Submission of Matters to a Vote of Security Holders

International Stem Cell Corporation (the "Company") held its Annual Meeting of Stockholders on June 9, 2022. The stockholders considered two proposals, which are described in more detail in the Company's definitive proxy statement dated April 28, 2022.

Proposal 1: Election of four directors to hold office until the 2023 Annual Meeting:






  A. Directors elected by holders of Series D Preferred Stock:




                    FOR      WITHHELD
Andrey Semechkin 2,457,143      0
Russell Kern     2,457,143      0




    B.  Directors elected by holders of all shares of stock (including shares of
        preferred stock voting on an as-converted basis):




                    FOR      WITHHELD
Donald A. Wright 7,648,278   101,283
Paul V. Maier    7,648,339   101,222




Broker Non-Votes: none

All of the foregoing candidates were elected.





Proposal 2: Advisory vote on compensation of the Company's named executive
officers:



  FOR     AGAINST ABSTAIN
7,544,159 200,375  5,027




Broker Non-Votes: none







  2

© Edgar Online, source Glimpses